Inventor
GANESAN RAJKUMAR
US33 patents
⚠️ This page may combine multiple inventors who share the name “GANESAN RAJKUMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN BIOTECH INC
23 patentsUS11667712B2Jun 6, 2023
Materials and methods for modulating t cell mediated immunity
JANSSEN BIOTECH INC2 citations72
US12077592B2Sep 3, 2024
GPRC5D chimeric antigen receptors and cells expressing the same
JANSSEN BIOTECH INC3 citations69
US12180278B2Dec 31, 2024
Antibody targeting CD22 and CD79B
JANSSEN BIOTECH INC2 citations68
US12084501B2Sep 10, 2024
Proteins comprising CD3 antigen binding domains and uses thereof
JANSSEN BIOTECH INC2 citations66
US12129310B2Oct 29, 2024
Materials and methods for enhanced linker targeting
JANSSEN BIOTECH INC0 citations62
US11639396B2May 2, 2023
Antibody binding to a linker peptide
JANSSEN BIOTECH INC0 citations62
US12492226B2Dec 9, 2025
Materials and methods for producing bioengineered virus specific lymphocytes
JANSSEN BIOTECH INC0 citations61
US11981932B2May 14, 2024
Materials and methods for the manufacture of pluripotent stem cells
JANSSEN BIOTECH INC1 citations61
US12492256B2Dec 9, 2025
Methods and compositions for modulating beta chain mediated immunity
JANSSEN BIOTECH INC0 citations59
US12448449B2Oct 21, 2025
Immune targeting molecules and uses thereof
JANSSEN BIOTECH INC0 citations59
US12264197B2Apr 1, 2025
Anti-Vβ17/anti-CD123 bispecific antibodies
JANSSEN BIOTECH INC0 citations59
US11965024B2Apr 23, 2024
Methods and compositions for modulating beta chain mediated immunity
JANSSEN BIOTECH INC0 citations59
US12077585B2Sep 3, 2024
Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses
JANSSEN BIOTECH INC0 citations58
US11866499B2Jan 9, 2024
Monospecific and multispecific anti-TMEFF2 antibodies and their uses
JANSSEN BIOTECH INC0 citations57
US12460001B2Nov 4, 2025
Proteins comprising CD3 antigen binding domains and uses thereof
JANSSEN BIOTECH INC0 citations54
US11952411B2Apr 9, 2024
Materials and methods of using engineered ligands
JANSSEN BIOTECH INC0 citations54
US12076413B2Sep 3, 2024
Compositions and methods for modulating delta gamma chain mediated immunity
JANSSEN BIOTECH INC0 citations49
US11926667B2Mar 12, 2024
Bioengineered T cell mediated immunity, materials and other methods for modulating cluster of differentiation IV and/or VIII
JANSSEN BIOTECH INC0 citations49
US12071466B2Aug 27, 2024
Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereof
JANSSEN BIOTECH INC0 citations46
US12522658B2Jan 13, 2026
Anti-CD79 chimeric antigen receptors, CAR-T cells, and uses thereof
JANSSEN BIOTECH INC0 citations43
US12134658B2Nov 5, 2024
Materials and methods for multidirectional biotransportation in virotherapeutics
JANSSEN BIOTECH INC0 citations41
US12103977B2Oct 1, 2024
Trispecific antibody targeting CD79b, CD20, and CD3
JANSSEN BIOTECH INC0 citations41
US11827708B2Nov 28, 2023
Proteins comprising HLA-G antigen binding domains and their uses
JANSSEN BIOTECH INC0 citations41
BOEHRINGER INGELHEIM INT
6 patentsUS11332541B2May 17, 2022
Multi-specific binding proteins for cancer treatment
BOEHRINGER INGELHEIM INT8 citations84
US11312785B2Apr 26, 2022
Antagonizing CD73 antibody
BOEHRINGER INGELHEIM INT10 citations77
US12173083B2Dec 24, 2024
Multi-specific binding proteins for cancer treatment
BOEHRINGER INGELHEIM INT2 citations71
US12528879B2Jan 20, 2026
Multi-specific binding proteins for cancer treatment
BOEHRINGER INGELHEIM INT0 citations61
US11267880B2Mar 8, 2022
Anti-Sema3A antibodies and their uses for treating eye or ocular diseases
BOEHRINGER INGELHEIM INT1 citations57
US11732045B2Aug 22, 2023
Multi-specific binding proteins for cancer treatment
BOEHRINGER INGELHEIM INT0 citations48
GANESAN RAJKUMAR
3 patentsUS8759491B2Jun 24, 2014
Modulators of hepatocyte growth factor activator
GANESAN RAJKUMAR2 citations59
US8435511B2May 7, 2013
Anti-hepsin antibodies and methods using same
GANESAN RAJKUMAR2 citations59
US8697386B2Apr 15, 2014
Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
GANESAN RAJKUMAR0 citations38